Home » Topics » BioWorld Science

BioWorld Science
RSS

Yamanouchi reports on GI drugs in development

Oct. 11, 1996

Gastrointestinal drugs in the pipeline at Fujisawa

Oct. 11, 1996

Axcan acquires enzyme preparation for pancreatic insufficiency

Oct. 11, 1996

Promising results from U.S. trial on Zadaxin for hepatitis C

Oct. 11, 1996

New hepatoprotectants from Nisshin Flour Milling

Oct. 11, 1996

Medeva acquires rights to nicotine for ulcerative colitis

Oct. 11, 1996

European approvals for Zantac

Oct. 11, 1996

Zenyaku Kogyo discloses anti-Helicobacter pylori agents

Oct. 11, 1996

Renal-urologic drugs in development at Yamanouchi

Oct. 11, 1996

Three renal-urologic drugs reported in the Fujisawa product pipeline

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...